Objective:This study aims to investigate the effect of bardoxolone methyl (CDDO-Me) on the hypoxia-induced activation of human pulmonary artery adventitia fibroblasts(PAAF)and potential mechanism. Methods:Human PAAF were cultured in vitro and randomly divided into four groups:the normoxia group(21% oxygen),the hypoxia group(1% oxygen),the hypoxia plus CDDO-Me group and the normoxia plus CDDO-Me group. Cell viability was determined by CCK-8 assay. Transwell assay was carried out to assess cell migration. The levels of reactive oxygen species(ROS),malondialdehyde(MDA),glutathione(GSH)and superoxide dismutase(SOD)were detected to evaluate the level of oxidative stress. The levels of transforming growth factor(TGF)-β1,tumor necrosis factor(TNF)-α and interleukin(IL)-1β were detected by ELISA assay. The expression of α-smooth muscle actin (α-SMA) and nuclear translocation of NF-κB(p65) were detected by immunofluorescence assay. The protein levels of α-SMA,collagen Ⅰ,vimentin,phospho-Smad3 and Smad3,phospho-p65 and p65 were determined by Western blot. Results:CDDO-Me treatment(62.5,125.0,250.0,500.0 nmol/L)decreased hypoxia-induced elevations of cell viability in a concentration dependent manner,which showed significant inhibition at concentration of 250.0 nmol/L and 500.0 nmol/L. CDDO-Me(500.0 nmol/L)remarkably inhibited hypoxia-induced migration and myofibroblast transformation of PAAF,which reflected in improvement of hypertrophy,decreases in expressions of α-SMA,collagenI and vimentin. In addition,CDDO-Me(500.0 nmol/L)significantly inhibited hypoxia-induced increased levels of ROS and MDA,decreased levels of GSH and SOD,and improved the ability of antioxidation. Hypoxia increased the secretion of TGF-β1 and activate TGF-β1/Smad3 signaling pathway in PAAF,which was attenuated by CDDO-Me(500.0 nmol/L). Besides,hypoxia-induced nuclear translocation of p65,phosphorylation of p65 protein,and the secretion of TNFα and IL-1β were inhibited by CDDO-Me treatment. Conclusion:CDDO-Me can inhibit hypoxia-induced proliferation,migration,myofibroblast transformation of PAAF,improve the antioxidation ability,and inhibit TGF-β1/Smad3 and NF-κB signaling pathway in PAAF.
[1] HUMBERT M,GUIGNABERT C,BONNET S,et al.Pa? thology and pathobiology of pulmonary hypertension:state of the art and research perspectives[J].Eur Respir J,2019,53(1):1801887
[2] MEYRICK B,REID L.Hypoxia and incorporation of 3 H ? thymidine by cells of the rat pulmonary arteries and alveo? lar wall[J].Am J Pathol,1979,96(1):51-70
[4] BELLO ?KLEIN A,MANCARDI D,ARAUJO A S,et al.Role of redox homeostasis and inflammation in the patho? genesis of pulmonary arterial hypertension[J].Curr Med Chem,2018,25(11):1340-1351
[5] DODSON M,DE LA VEGA M R,CHOLANIANS A B,et al.Modulating NRF2 in disease:timing is everything[J].Annu Rev Pharmacol Toxicol,2019,59:555-575
[6] CHIN M P,BAKRIS G L,BLOCK G A,et al.Bardoxolone methyl improves kidney function in patients with chronic kidney disease stage 4 and type 2 diabetes:Post?Hoc analy? ses from bardoxolone methyl evaluation in patients with chronic kidney disease and type 2 diabetes study[J].Am J Nephrol,2018,47(1):40-47
[7] CHERTOW G M,APPEL G B,BLOCK G A,et al.Effects of bardoxolone methyl on body weight,waist circumfer? ence and glycemic control in obese patients with type 2 di? abetes mellitus and stage 4 chronic kidney disease[J].J Diabetes Complications,2018,32(12):1113-1117
[8] WANG Y Y,ZHANG C Y,MA Y Q,et al.Therapeutic effects of C?28 methyl ester of 2?cyano?3,12?dioxoolean? 1,9?dien?28?oic acid(CDDO?Me;bardoxolone methyl)on radiation?induced lung inflammation and fibrosis in mice [J].Drug Des Devel Ther,2015,9:3163-3178
[9] KULKARNI A A,THATCHER T H,HSIAO H M,et al.The triterpenoid CDDO ? Me inhibits bleomycin ? induced lung inflammation and fibrosis[J].PLoS One,2013,8(5):e63798